AOD-9604 vs Tesamorelin: Two Approaches to Growth Hormone-Related Research Durham Peptides May 9 7 min read Updated: 3 days ago AOD-9604 vs Tesamorelin GH research comparison Durham Peptides Canada AOD-9604 and tesamorelin are both growth hormone-related research peptides but they engage GH biology from completely opposite directions
Adjustments follow data such as dose changes, switching peptides, adding supportive therapies like anti-inflammatories, or pausing treatment if adverse events occur
I will cover each of these topics below, in the treatment section
The Right Standards Full transparency, expert formulation, and stringent quality control
RFK himself called the original ban illegal and argued that it had created the very grey market it was supposedly designed to prevent
In the trial, 6.5% of participants taking Wegovy had a major adverse cardiovascular event compared to 8% on placebo, according to the FDA